Now I have a thorough understanding of the paper. Let me construct the final review.

## Summary

The paper introduces NormIntSleep, a representation learning framework that projects deep neural network embeddings onto a clinically meaningful feature space (FeatShort, grounded in AASM guidelines), enabling glass-box models (decision trees, XGBoost, CatBoost) to provide domain-aligned explanations while maintaining competitive accuracy. It also proposes AlignmentDT, a metric to quantify how well a decision tree's splits align with clinical domain knowledge. Experiments on two sleep staging datasets (ISRUC, PhysioNet) show that NormIntSleep-DecisionTree achieves both substantially higher accuracy than FeatShort-DecisionTree (79.4% vs. 71%) and a perfect AlignmentDT score of 1.0, with decision tree splits validated qualitatively by a practicing sleep clinician.

## Strengths

- **Sound and novel framework design**: NormIntSleep's two-stage pipeline (pre-train DNN → learn linear projector onto FeatShort feature space → train glass-box model) is a clean, principled way to combine the representational power of deep learning with clinically grounded interpretability. The modular architecture (Algorithms 1 and 2) is clearly described and potentially generalizable.

- **AlignmentDT metric**: The proposed metric provides a concrete, quantifiable way to measure domain-grounded interpretability beyond accuracy. NormIntSleep-DecisionTree achieves a perfect score of 1.0, while FeatLong-DecisionTree scores 0 and SERF scores 0.44, demonstrating that the projected representations produce clinically meaningful decision trees.

- **Significant accuracy improvement over FeatShort-DecisionTree**: NormIntSleep-DecisionTree improves accuracy from 71% to 79.4% on PhysioNet and from ~69.8% to ~79.1% on ISRUC compared to directly using FeatShort features with a decision tree. This is a concrete demonstration that the projection adds value beyond using the clinical features directly.

- **Multi-faceted validation**: The paper provides (a) quantitative accuracy comparisons across multiple glass-box models, (b) a new domain-alignment metric, (c) qualitative clinician review of decision tree splits, and (d) SHAP analysis confirming that top features align with clinical knowledge (beta waves for Wake, slow waves for N3, EOG activity for REM).

- **Evaluation on two diverse public datasets**: Results are reported on both ISRUC (subjects with sleep disorders) and PhysioNet (healthy controls + insomnia patients), demonstrating generalization across populations.

## Weaknesses

### Fatal
None.

### Major
- **Missing AlignmentDT comparison for FeatShort-DecisionTree**: The paper does not report the AlignmentDT score for FeatShort-DecisionTree — the most natural baseline for the interpretability claim. Since FeatShort is explicitly designed from AASM clinical guidelines, a FeatShort-DecisionTree would likely also achieve a high AlignmentDT score. The comparison is currently only against FeatLong-DecisionTree (AlignmentDT=0), which uses deliberately non-clinical features, and SERF (0.44). Without this comparison, the claim that NormIntSleep provides "significantly better alignment with domain expertise relative to other methods" (Section 6) is not fully supported for the most relevant baseline. This gap undermines a central thesis of the paper.

### Minor
- **Abstract overclaims relative to FeatLong**: The abstract states "NormIntSleep outperforms prior interpretable techniques with 0.814–0.847 accuracy, 0.787–0.793 F1-score, 0.759–0.788 κ." However, FeatLong-CatBoost (an interpretable feature-based method) achieves 0.811–0.862 accuracy, 0.775–0.811 F1, and 0.754–0.810 κ on the same datasets. NormIntSleep's ranges are competitive but do not consistently outperform FeatLong. The paper body honestly acknowledges FeatLong as "the sole exception" (Section 5), but the abstract lacks this caveat and is misleading as written.

- **Single train-test split without variance in main table**: Results are based on a single 9:1 subject-level split with a fixed seed. The paper mentions that confidence intervals are in Appendices I, but the main results table (Table 3) presents only point estimates. Given the high inter-subject variability in sleep data, it is difficult to assess whether performance differences (e.g., NormIntSleep vs. FeatLong) are statistically significant without variance information in the main text.

- **Clinician validation is qualitative and non-blinded**: The clinician's observations of decision tree nodes (Section 5.1) are a useful sanity check, but the evaluation is informal, not blinded, and covers only one dataset (PhysioNet). This is acceptable as a secondary validation but does not constitute rigorous evidence that the tree is clinically superior.

### Trivial
None.

## Nice-to-Haves
- Report Reconstruction error (e.g., MAE per feature) of the linear projection to demonstrate how faithfully the projected representations approximate the actual FeatShort features.
- Compare decision tree splits between NormIntSleep-DecisionTree and FeatShort-DecisionTree to directly show whether NormIntSleep produces more clinically meaningful splits beyond accuracy gains.
- Report AlignmentDT for FeatShort-DecisionTree (this is listed as a Major weakness above — the "nice-to-have" would be the deeper analysis comparing the actual split structure).

## Removed Points

These points are flagged to be removed, treat them with caution:

1. **"AlignmentDT equation missing from main text" (Harsh Critic Point 3)**: The equation is absent in the parsed text due to a missing rendered image. This is a parser/formatting artifact, not an author error. The paper references "Eq. 1," confirming its existence in the original submission. Removed per hard rule on parser artifacts.

2. **"FeatLong citation cut off" (Harsh Critic: Section 3.3 note)**: This is a parser artifact from image/equation rendering. Removed per hard rule on formatting artifacts.

3. **"Generalization to another domain needed" (Harsh Critic: Obvious Next Steps #1)**: This demands the paper address problems outside its stated scope (sleep staging). The paper provides guidelines for adoption elsewhere but does not claim to have demonstrated cross-domain generalization. Removed as scope creep per soft rule.

4. **"Not yet released" or reproducibility concerns about cited baselines**: No such claims were made, but if any existed they would be removed per hard rule.

5. **Strength from Strength Finder about "superior empirical performance over prior interpretable methods"**: This strength is retained but qualified in my Strengths section. The Strength Finder's phrasing was slightly too strong given the FeatLong comparison.

## Novel Insights

The reviews do not surface genuinely novel insights beyond the paper's own contributions. The key observation — that projecting deep embeddings onto a clinically-designed feature space via linear regression can simultaneously improve both accuracy (vs. using features directly) and interpretability (vs. using generic features) — is already articulated in the paper.

## Suggestions

1. **Report AlignmentDT for FeatShort-DecisionTree**: This single addition would either (a) strengthen the paper considerably (if FeatShort scores lower than 1.0) or (b) clarify the actual contribution (if both score 1.0, the contribution shifts to accuracy improvement while maintaining alignment). Either outcome is informative.

2. **Revise the abstract**: Replace "outperforms prior interpretable techniques" with more precise language that acknowledges FeatLong's competitive performance, e.g., "achieves competitive accuracy with prior interpretable techniques while providing the highest AlignmentDT score."

3. **Move confidence intervals or cross-validation results into the main table**: Add error bars or confidence intervals to Table 3, or at minimum note statistical significance of key comparisons in the main text.

4. **Consider a more rigorous clinician evaluation**: A small blinded comparison (e.g., asking the clinician to identify which of two trees is NormIntSleep vs. FeatShort) would provide stronger evidence for the interpretability claim.

## Score and Decision

**Overall assessment**: The paper proposes a novel, well-motivated framework with a clear methodology. The core idea is sound, the experiments are reasonably thorough, and the paper is well-structured. The main weakness is the missing AlignmentDT comparison for FeatShort-DecisionTree, which leaves a gap in the central interpretability claim. The abstract overstatement is also misleading. However, these issues are addressable in revision. The paper makes a real contribution to the interpretable ML for healthcare literature.

**Originality**: Good — the combination of DNN embeddings with clinically-designed features via a learned projection is novel.

**Importance**: High — interpretable sleep classification has direct clinical utility.

**Claims support**: Moderate — the accuracy claims need qualification relative to FeatLong, and the AlignmentDT claims need the FeatShort-DecisionTree comparison.

**Soundness**: Good methodology, evaluation gap in the AlignmentDT comparison.

**Clarity**: Good — the method and architecture are clearly described.

**Value**: Positive — the framework, metric, and empirical results are useful contributions.

MY FINAL SCORE: <pineapple>6.0</pineapple>
MY FINAL DECISION: <orange>Accept</orange>